Why is Emmessar Biotech falling/rising?

As of 18-Sep, Emmessar Biotech & Nutrition Ltd is experiencing a price increase, currently at 39.40, which reflects a rise of 0.52 or 1.34%. The stock has shown strong performance recently, gaining 49.19% over the last four days and outperforming its sector by 1.84% today. Additionally, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. The stock's performance over the past week has been particularly impressive, with a return of 43.85%, compared to the Sensex's gain of only 1.80%. However, the year-to-date performance shows a decline of 14.90%, which contrasts with the Sensex's increase of 6.24%.
In the broader market context, Emmessar Biotech's recent returns significantly outpace the benchmark, suggesting strong investor interest and confidence in the stock. The notable increase in delivery volume, which rose by 748.88% against the 5-day average, further indicates rising investor participation and liquidity, making the stock more attractive for trading. Despite the positive short-term performance, the year-to-date decline highlights potential volatility or challenges that may have affected the stock earlier in the year. Overall, the current upward movement appears to be driven by strong recent gains and increased trading activity, despite a less favorable longer-term performance.